LGD3033 maximizes muscle dry mass gain and strengthens metabolism by selectively acting on androgen receptors - it increases strength and accelerates recovery. Choose Powerock Pharma for certified quality and breakthrough research results.
LGD3033 is an advanced research compound from the SARM (selective androgen receptor modulator) group. This substance (CAS: 1182367-47-0) has been designed for selective interaction with androgen receptors in muscle and bone tissues. Its unique selectivity makes LGD3033 a valuable tool in studies on muscle tissue growth and lean mass preservation.
Discover the potential laboratory properties of LGD3033 that make it a valuable compound in scientific research.
Supports the development of muscle tissue through selective receptor modulation.
Helps maintain muscle tissue during studies on calorie deficit.
Speeds up the recovery processes in studied tissues.
Improves performance in laboratory conditions.
Precisely targets selected tissues in research.
Supports research on muscle strength development.
Manufactured according to GMP, HACCP, and ISO 13485 standards.
Provides reproducible results in laboratory conditions.
At Powerock Pharma, our priority is to provide only the highest quality research substances. Every batch of LGD3033 is produced in factories compliant with GMP, HACCP, and ISO 13485 standards. Our strict quality control oversight and use of the latest testing procedures ensure not only the effectiveness of our products but also their safety and reliability. Collaboration with leading laboratories ensures purity and efficacy of substances, providing consistent and repeatable results. By choosing Powerock Pharma, you are opting for excellence, security, and unmatched quality of research materials.
LGD3033 should be taken orally under laboratory conditions. Each capsule contains precisely measured 10mg of the research substance for accuracy in experiments.
To maintain a consistent level of the compound in research, it is recommended to administer the substance once a day at a fixed time.
The suggested research period is 8-12 weeks for accurate monitoring of results.
For research, it is recommended to start with 5mg per day, with the possibility of adjusting depending on the research protocol.
The standard dose in research is 10mg per day, which can be adjusted according to the research objectives.
It is essential to regularly monitor research parameters, including muscle tissue development and overall performance.
Tip: 1 MG = 1000 MCG
